Blog

In March 2016, the FDA asked the National Academies of Sciences, Engineering, and Medicine (NASEM) to outline the state of the science regarding prescription opioid abuse and misuse, as well as the evolving role that opioids play in pain management.  We greatly appreciate all the work done by NASEM over the past year to produce the comprehensive report released in July, which includes recommendations for the FDA and others on this important issue.

FDA issues safety communication about illegal use of injectable silicone for body contouring and associated health risks.

Despite blasting pharma for “getting away with murder” on multiple occasions, President Donald Trump is expected to pick a former pharmaceutical executive to lead the Department of Health and Human Services, Bloomberg reports.

The FDA and its new Trump-picked commissioner Scott Gottlieb took to social media to talk up the Agency’s plans to speed up the drug regulation process.

Lagging flu vaccination rates in the U.S., especially among children, have scientists working to take the “Ow!” out of immunization.  Enter an experimental patch with dissolvable microneedles.  A phase 1 study shows that a dissolvable microneedle flu patch is safe and can elicit an immune response as robust as an intramuscular injection.

Martin Shkreli is undisputably weird, but he is not a criminal.  That is the essence of his defense attorney’s opening arguments in Shkreli’s securities-fraud trial, which opened in June.

Most people of normal weight do not crave a cheeseburger right after they eat a full meal.  However, some people who struggle with obesity are still just as ravenous after they have chowed down as they were before.  Now scientists at Beth Israel Deaconess Medical Center (BIDMC) believe they have discovered why the process of feeling too full to eat any more goes awry in some people — and the culprit, they say, lies deep in the brain.

ISO’s popular standard for auditing management systems is under revision and has just reached the first voting stage, a crucial step in its development.

There is no denying that financial incentives for orphan drug development spawned meds that have saved hundreds of thousands of lives.  However, they have also helped mass-market drug makers rack up millions in incentives, tax breaks and patent-protected profits — in some cases through monopoly pricing, a new report contended.

After seeing drug overdoses become the state’s leading cause of accidental deaths, officials in Ohio have had enough.  In a new lawsuit filed in May, Ohio Attorney General (AG) Mike DeWine is going after Teva, Allergan, Johnson & Johnson, Purdue and Endo for alleged “fraudulent marketing practices” on powerful opioid painkillers.